89bio, Inc. (ETNB) Misses Q4 EPS by 27c
89bio, Inc. (NASDAQ: ETNB) reported Q4 EPS of ($1.02), $0.27 worse than the analyst estimate of ($0.75).
For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.
89bio, Inc. (NASDAQ: ETNB) reported Q4 EPS of ($1.02), $0.27 worse than the analyst estimate of ($0.75).
For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.